Showing 1 - 4 results of 4 for search 'Stefan Bissinger', query time: 0.02s Refine Results
  1. 1
    301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition

    301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition by Christina Hartl, Tillmann Michels, Ronny Milde, Vanessa Klein, Philipp Beckhove, Hannes Loferer, Stefan Bissinger

    Published 2021-11-01
    Article
  2. 2
    Periostin Limits Tumor Response to VEGFA Inhibition

    Periostin Limits Tumor Response to VEGFA Inhibition by Ioanna Keklikoglou, Ece Kadioglu, Stefan Bissinger, Benoît Langlois, Axel Bellotti, Gertraud Orend, Carola H. Ries, Michele De Palma

    Published 2018-03-01
    Get full text
    Article
  3. 3
    60 Development of a gene signature to predict the anti-tumor response of the salt-inducible kinase (SIK) inhibitor OMX-0407

    60 Development of a gene signature to predict the anti-tumor response of the salt-inducible kinase (SIK) inhibitor OMX-0407 by Hannes Loferer, Stefan Bissinger, Ilona-Petra Maser, Sonja Lacher, Marisa Stebegg, Vincent Piras, Barbara Kracher, Kai Quirin, Murray Yule

    Published 2023-11-01
    Article
  4. 4
    Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo

    Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo by Cornelia Fischer, Michael W. Munks, Ann B. Hill, Richard A. Kroczek, Stefan Bissinger, Verena Brand, Martina Schmittnaegel, Sabine Imhof-Jung, Eike Hoffmann, Frank Herting, Christian Klein, Hendrik Knoetgen

    Published 2020-01-01
    Get full text
    Article

Search Tools: